Quest Diagnostics 2007 Annual Report Download - page 117

Exhibit
Number Description
10.11* Joinder Agreement, dated as of November 10, 2006, executed and delivered by LabOne, Inc., Central
Plains Laboratories, LLC, LabOne of Ohio, Inc., ExamOne World Wide, Inc. and Systematic Business
Services, Inc., in favor of Quest Diagnostics Receivables Inc., as the Buyer with respect to the Second
Amended and Restated Receivables Sale Agreement dated as of April 20, 2004 among the Company
and each of its direct or indirect wholly owned subsidiaries who is or hereafter becomes a seller
thereunder, as the Sellers, and the Buyer.
10.12 Term Loan Credit Agreement dated as of December 19, 2003, among the Company, certain subsidiary
guarantors of the Company, the lenders party thereto, and Sumitomo Mitsui Banking Corporation
(filed as an Exhibit to the Company’s 2003 annual report on Form 10-K and incorporated herein by
reference)
10.13 First Amendment to Term Loan Credit Agreement dated as April 20, 2004, among the Company,
certain subsidiary guarantors of the Company, the lenders party thereto, and Sumitomo Mitsui
Banking Corporation (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the
quarter ended June 30, 2004 and incorporated herein by reference)
10.14 Interim Credit Agreement dated as of January 31, 2007, among the Company, certain subsidiary
guarantors of the Company, the lenders party thereto, and Bank of America, N.A. (filed as an Exhibit
to the Company’s current report on Form 8-K (Date of Report: January 31, 2007) and incorporated
herein by reference)
10.15 Credit Agreement dated as of May 31, 2007, among the Company, certain subsidiary guarantors of
the Company, the lenders party thereto, Bank of America, N.A., as Administrative Agent, Morgan
Stanley Senior Funding, Inc., as Syndication Agent, Barclays Bank Plc, JPMorgan Chase Bank, N.A.,
Merrill Lynch Bank, USA and Wachovia Bank, National Association, as co-Documentation Agents,
and Morgan Stanley Senior Funding, Inc. and Banc of America Securities LLC, as Joint Lead
Arrangers and Joint Book Runners (filed as an Exhibit to the Company’s current report on Form 8-K
(Date of Report: May 31, 2007) and incorporated herein by reference)
10.16 Bridge Credit Agreement dated as of May 31, 2007, among the Company, certain subsidiary
guarantors of the Company, the lenders party thereto, Bank of America, N.A., as Administrative
Agent, Morgan Stanley Senior Funding, Inc., as Syndication Agent, Barclays Bank Plc, JPMorgan
Chase Bank, N.A., Merrill Lynch Bank, USA and Wachovia Bank, National Association, as co-
Documentation Agents, and Morgan Stanley Senior Funding, Inc. and Banc of America Securities
LLC, as Joint Lead Arrangers and Joint Book Runners (filed as an Exhibit to the Company’s current
report on Form 8-K (Date of Report: May 31, 2007) and incorporated herein by reference)
10.17 Stock and Asset Purchase Agreement dated as of February 9, 1999, among SmithKline Beecham plc,
SmithKline Beecham Corporation and the Company (the “Stock and Asset Purchase Agreement”)
(filed as Appendix A of the Company’s Definitive Proxy Statement dated May 11, 1999 and
incorporated herein by reference) (Commission File Number 001-12215)
10.18 Amendment No. 1 dated August 6, 1999, to the Stock and Asset Purchase Agreement (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: August 16, 1999) and
incorporated herein by reference) (Commission File Number 001-12215)
10.19 Stockholders Agreement dated as of August 16, 1999, between SmithKline Beecham plc and the
Company (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: August
16, 1999) and incorporated herein by reference) (Commission File Number 001-12215)
10.20 Amended and Restated Global Clinical Trials Agreement, dated as of December 19, 2002, between
SmithKline Beecham plc dba GlaxoSmithKline and the Company (filed as an Exhibit to post effective
amendment No. 1 to the Company’s Registration Statement on Form S-4 and incorporated herein by
reference) (Commission File Number 333-88330)
10.21‡ Amended and Restated Employee Stock Purchase Plan (filed as an Exhibit to the Company’s quarterly
report on Form 10-Q for the quarter ended September 30, 2007 and incorporated herein by reference)
10.22‡ 1996 Employee Equity Participation Program, as amended (filed as an Exhibit to the Company’s
quarterly report on Form 10-Q for the quarter ended September 30, 2002 and incorporated herein by
reference) (Commission File Number 001-12215)
10.23‡ Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan (filed as
an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2007
and incorporated herein by reference)
10.24‡ Form of Non-Qualified Stock Option Agreement (filed as an Exhibit to the Company’s current report
on Form 8-K (Date of report: February 15, 2006) and incorporated herein by reference)
10.25‡ Form of Non-Qualified Stock Option Agreement dated as of February 12, 2007 (filed as an Exhibit to
the Company’s 2006 annual report on Form 10-K and incorporated herein by reference)
10.26* Non-Qualified Stock Option Agreement, dated as of February 12, 2007, between the Company and
Surya N. Mohapatra
10.27‡ Form of Performance Share Agreement (2007-2009 Performance Period) (filed as an Exhibit to the
Company’s 2006 annual report on Form 10-K and incorporated herein by reference)
E-3